Description
As the boundaries between engineering, biology, and medicine continue to blur, 3D bioprinting is poised to redefine the future of healthcare. Join us for “The Frontier of 3D Bioprinting,” a cutting-edge virtual event hosted by 3DHEALS, where global leaders in science, technology, and innovation converge to explore the next wave of breakthroughs in biofabrication. From printing functional tissues to enabling organ-on-a-chip models and personalized regenerative therapies, from functional heart tissue to cancer therapy breakthrough, this event will showcase trailblazing companies, scientists, and thought leaders at the forefront of this transformative field. Whether you’re an academic, entrepreneur, investor, or healthcare professional, you’ll gain valuable insights into the latest technical advancements, commercialization strategies, and clinical applications shaping the bioprinting ecosystem.Don’t miss your chance to learn directly from the pioneers pushing the limits of what’s possible in bioprinting.
Speakers:
Mike Graffeo
Mike is the CEO and co-founder of FluidForm, which uses 3D printing to build living human tissue to improve the treatment of disease. In over 20 years in the life sciences, Mike has brought four novel products through the FDA that have generated over $20 billion in sales in both startup and growth organizations. Throughout his career, he has worked on the forefront of medical technologies, translating highly complex products and clinical data into successful businesses, in the US and around the world. He is a graduate of Cornell University (B.S. Engineering Physics, M.Eng. Mechanical Engineering) and Harvard Business School (MBA), where he was a Baker Scholar.
Annaliese Vojnich
Annaliese Vojnich is a dynamic business development leader at the forefront of bioprinting and precision dispensing technology. With a foundation in nutritional sciences and research from the University of Georgia, Annaliese has built a career at the intersection of science, technology, and medical innovation, driven by a passion for advancing technology that improves lives.
She currently serves as the Business Development and Technical Sales Manager at ViscoTec America, where she oversees the Puredyne® brand and ViscoTec’s Hygienic Solutions division. Her expertise spans high precision extrusion-based dispensing for bioprinting, pharmaceutical, medical, consumer goods, and all FDA-regulated applications. Annaliese is recognized for her ability to translate complex technical concepts into tailored solutions, enabling clients to optimize manufacturing processes and accelerate product development. She actively fosters impactful collaborations across academia, startups, and established industry leaders to push the boundaries of tissue engineering, regenerative medicine, and manufacturing.
Annaliese’s professional journey—from lab management roles in genetic research to technical sales leadership in FDA-regulated environments—reflects her commitment to meaningful, purpose-driven work that bridges innovation and practical application. She is passionate about empowering teams, driving strategic growth, and cultivating long-term partnerships grounded in trust and scientific excellence.
When she’s not navigating innovation spaces and advancing project applications, Annaliese is an endurance athlete and brain surgery survivor who leads with grit, empathy, and unwavering purpose. Her advocacy extends across health and wellness, women’s empowerment, and animal welfare, where she actively contributes to community initiatives and mentorship programs. She continuously seeks to inspire others through resilience and authentic leadership.
Dr. Jorge Madrid-Wolff
Jorge Madrid-Wolff earned his PhD in Photonics at EPFL (Switzerland, 2023), where he explored methods to push tomographic volumetric additive manufacturing to non-transparent materials and large-scale volumetric 3D printing. After a short postdoc, he joined Readily3D as Application Scientist. In this role, Jorge designs bespoke tools and protocols for Readily3D’s customers, with the aim of expanding the range of applications enabled by our unique technology.
His work has turned around volumetric light projection systems, first for imaging and microscopy, and then for additive manufacturing.
Karolina Valente
Dr. Karolina Valente is the Founder and CEO of VoxCell BioInnovation, a biotechnology company advancing 3D bioprinting to develop human-like cancer tissue models and accelerate drug discovery. With over 12 years of experience in tissue engineering, she holds a Ph.D. in Mechanical Engineering with a focus on bioprinting and drug delivery systems. Under her leadership, VoxCell has grown from 5 to 20 employees and raised over $10M CAD.
Her contributions to biotechnology and cancer research have earned her and VoxCell multiple accolades. In 2023, Douglas Magazine recognized VoxCell as one of its 10 to Watch winners, acknowledging the company’s significant contributions to biotechnology and cancer research. In 2024, Life Sciences BC named VoxCell to its Companies to Watch – Recognition Honour Roll, highlighting its potential and achievements in the life sciences sector. Most recently, The Globe and Mail’s Report on Business 2025 Changemakers Award recognized Karolina as one of 20 emerging leaders reinventing how business is done in Canada.
Passionate about scientific innovation, gender equity, and the future of biotechnology, she continues to drive transformative change in oncology research and 3D bioprinting.
Moderator:
Dr. Jenny Chen
Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.
Reviews
There are no reviews yet.